|
AEROCHAMBER Plus* VHC
The Clinical Evidence is Clear
For over 20 years, Trudell Medical International
has developed, manufactured and marketed some of the world’s most effective
aerosol drug delivery devices. Our strength lies in product development
around core capabilities in mechanical, electronic and biomedical
engineering design, complimented by a state-of-the-art aerosol research
laboratory and the experience gained by marketing products into over 96
countries world-wide.
Throughout these past 20 years, over 300 in vivo and in vitro peer-reviewed
articles have been published and recognized in journals such as the New
England Journal of Medicine, Journal of Pediatrics, Lancet, Archives of
Childhood Diseases, Pediatric Pulmonology and CHEST, to name a few. As a
result of the evidence-based clinical application of the AeroChamber*
brand of valved holding chambers (VHC), the AeroChamber Plus*
VHC has become the world-wide market leader in valved holding chambers and
is the only full line of products specifically designed for each patient type.
Studies conclude that the AeroChamber Plus* VHC is effective not
only in adults suffering from chronic airway obstruction, but also in
infants and children.1 The results of a study conducted in
the UK among asthma sufferers and parents of children with asthma concluded
that the AeroChamber* VHC is the preferred choice as it is
easy to use, easy to learn, most portable and most modern.2
To access this clinical information, simply use our Abstract Search menu
within www.trudellmed.com or click
on any of the Study Summary links. These Study Summaries were designed
to provide easy access to the most relevant clinical information on the
AeroChamber* brand of valved holding chambers within the areas of
Pediatrics, Hospital and In Vivo applications. A further Study Summary,
Use of the AeroChamber* Brand of Valved Holding Chambers,
contains abstracts regarding the comparison of small versus large volume
spacers, management of acute asthma in children, cost effectiveness of
spacers versus nebulizers, effect of electrostatic charge, lung deposition,
effect of inhalation technique and adult asthma.
As a health care provider, we invite you to review the literature and gain a
better understanding of the proven performance and safety profile of our
AeroChamber* brand of valved holding chambers.
(1) "Deposition pattern of
radiolabeled salbutamol inhaled from a metered dose inhaler by means of a
spacer with mask in young children with airway obstruction." A. Tal et al, J
Pediatr 1996; 128:479-84.
(2) NOP Healthcare, UK, March 2000
* trade marks and registered trade marks of
Trudell Medical International
© Trudell Medical International 2005. All
rights reserved
MD-294A-0805 |